Special NoticePosted Sep 23, 2026·Responses due Sep 24, 2026

Replacement of Aging AgilePulse IM Systems to Support In Vivo Electroporation and Research Continuity,

National Institutes of Health · NATIONAL INSTITUTES OF HEALTH OLAO

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
334516
Value
Not stated
Solicitation
PCA-NIAID-04170
Set-aside
None stated
PSC
Not stated
Place
Bethesda, MD, USA
Contact
Veenu Varma (veenu.varma@nih.gov)
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation PCA-NIAID-04170 in this department, oldest first.

Early notice
  • Sep 23, 2026 · this notice
    Special Notice
Solicitation
None posted
Award
Not yet. Typical award: Nov 2, 2026 to Jul 25, 2027, middle of the range Nov 26, 2026.
Measured from 68 past early notices at National Institutes of Health that later posted an award (middle half of cases, counted from Sep 23, 2026).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

What the notice says

Title: Replacement of Aging AgilePulse IM Systems to Support In Vivo Electroporation and Research Continuity This is a Notice of Intent to Sole Source (NOI), not a request for proposal. The National Cancer Institute intends to negotiate on an other-than-full-and-open competition basis with Harvard BioScience Inc. Purchase of two (2) Harvard Apparatus AgilePulse IM Systems with associated needle arrays, handles, installation/training services, and Silver Service Plans to replace aging electroporation systems supporting in vivo gene delivery research within the NIAID Vaccine Research Center. The… (show all)

replacement systems will improve operational reliability, reduce downtime, maintain consistency with established research protocols, and ensure continuity of ongoing research studies. While this pre-solicitation does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy this requirement. Such documentation shall be evaluated solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Interested parties may identify their interest and capability to respond to the requirement by referencing �PCA-NIAID-04170� The statutory authority for this sole source requirement is 41 U.S.C. 3204(b)(2) as implemented by FAR Overhaul 12.102(a) only one source is available. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable products may submit a capability statement via email to Veenu Varma at: Veenu.varma@nih.gov by 12:00 pm EASTERN Daylight Time, Wednesday, September 24, 2026. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Veenu Varma at veenu.varma@nih.gov.

Who won similar work

10 award notices on SAM.gov in the last 24 months. Match: Same office, same NAICS 334516.

WinnerAwardsValueLast
BRUKER NANO, INC · $BRKR1$230KAug 14, 2026
Sony Biotechnology Inc.1$227KAug 17, 2026
NEWPORT CORP1$212KJul 8, 2026
AMUZA INC.1$115KJul 10, 2026
PARSE BIOSCIENCES, INC.1$67KJul 8, 2026
Mirion Technologies (Capintec), Inc.1$56KJun 29, 2026
NIKON INSTRUMENTS INC1$40KSep 25, 2026
SR RESEARCH LIMITED1$37KJul 8, 2026
BECKMAN COULTER, INC1$31KJul 10, 2026
Revvity Health Sciences, Inc.1$21KOct 9, 2026

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.

Latest awards

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
  • 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 0 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.

  • 1 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.